New York State Common Retirement Fund Rocket Pharmaceuticals, Inc. Transaction History

New York State Common Retirement Fund

  • $74.9 Billion
  • Q3 2025

A detailed history of New York State Common Retirement Fund transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 15,117 shares of RCKT stock, worth $46,106. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,117
Previous 15,117 -0.0%
Holding current value
$46,106
Previous $37,000 32.43%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Oct 08, 2025
SELL
$11.35 - $18.82 $89,665 - $148,678
-7,900 Reduced 34.32%
15,117 $190,000
Q4 2024

Jan 31, 2025
SELL
$11.35 - $18.82 $89,665 - $148,678
-7,900 Reduced 34.32%
15,117 $190,000
Q3 2024

Oct 08, 2025
BUY
$17.6 - $25.88 $139,040 - $204,452
7,900 Added 52.26%
23,017 $425,000
Q3 2024

Oct 28, 2024
SELL
$17.6 - $25.88 $80,960 - $119,048
-4,600 Reduced 16.66%
23,017 $425,000
Q2 2024

Oct 08, 2025
BUY
$20.66 - $26.72 $258,250 - $334,000
12,500 Added 82.69%
27,617 $594,000
Q2 2024

Jul 31, 2024
SELL
$20.66 - $26.72 $276,720 - $357,887
-13,394 Reduced 32.66%
27,617 $595,000
Q1 2024

Oct 08, 2025
BUY
$26.16 - $30.74 $677,387 - $795,981
25,894 Added 171.29%
41,011 $1.1 Million
Q1 2024

May 07, 2024
BUY
$26.16 - $30.74 $362,002 - $425,380
13,838 Added 50.93%
41,011 $1.11 Million
Q4 2023

Oct 08, 2025
BUY
$16.78 - $31.94 $202,299 - $385,068
12,056 Added 79.75%
27,173 $814,000
Q4 2023

Feb 01, 2024
BUY
$16.78 - $31.94 $51,162 - $97,385
3,049 Added 12.64%
27,173 $814,000
Q3 2023

Oct 08, 2025
BUY
$15.07 - $24.05 $135,735 - $216,618
9,007 Added 59.58%
24,124 $494,000
Q3 2023

Nov 07, 2023
BUY
$15.07 - $24.05 $20,932 - $33,405
1,389 Added 6.11%
24,124 $494,000
Q2 2023

Oct 08, 2025
BUY
$16.59 - $23.6 $126,382 - $179,784
7,618 Added 50.39%
22,735 $451,000
Q2 2023

Aug 07, 2023
SELL
$16.59 - $23.6 $99,208 - $141,128
-5,980 Reduced 20.83%
22,735 $452,000
Q1 2023

Oct 08, 2025
SELL
$15.79 - $22.6 $78,681 - $112,615
-4,983 Reduced 14.79%
28,715 $491,000
Q1 2023

May 02, 2023
SELL
$15.79 - $22.6 $78,681 - $112,615
-4,983 Reduced 14.79%
28,715 $492,000
Q4 2022

Oct 08, 2025
BUY
$15.5 - $22.76 $288,005 - $422,903
18,581 Added 122.91%
33,698 $659,000
Q4 2022

Jan 30, 2023
BUY
$15.5 - $22.76 $77,314 - $113,526
4,988 Added 17.37%
33,698 $659,000
Q3 2022

Nov 08, 2022
BUY
$12.37 - $18.41 $1,274 - $1,896
103 Added 0.36%
28,710 $458,000
Q2 2022

Aug 04, 2022
SELL
$7.96 - $16.64 $398 - $832
-50 Reduced 0.17%
28,607 $394,000
Q1 2022

May 05, 2022
SELL
$13.16 - $23.68 $829 - $1,491
-63 Reduced 0.22%
28,657 $455,000
Q4 2021

Feb 02, 2022
SELL
$21.52 - $36.02 $64 - $108
-3 Reduced 0.01%
28,720 $627,000
Q3 2021

Nov 02, 2021
SELL
$27.42 - $48.97 $734,526 - $1.31 Million
-26,788 Reduced 48.26%
28,723 $859,000
Q2 2021

Aug 02, 2021
BUY
$39.41 - $47.25 $977,801 - $1.17 Million
24,811 Added 80.82%
55,511 $2.46 Million
Q4 2020

Feb 08, 2021
SELL
$23.3 - $59.57 $62,910 - $160,839
-2,700 Reduced 8.08%
30,700 $1.68 Million
Q2 2020

Aug 07, 2020
BUY
$13.32 - $22.61 $61,272 - $104,006
4,600 Added 15.97%
33,400 $699,000
Q4 2019

Feb 05, 2020
SELL
$11.07 - $24.23 $18,819 - $41,191
-1,700 Reduced 5.57%
28,800 $655,000
Q2 2019

Aug 09, 2019
BUY
$15.0 - $19.81 $109,500 - $144,613
7,300 Added 31.47%
30,500 $458,000
Q2 2018

Aug 10, 2018
BUY
$14.58 - $23.0 $338,256 - $533,600
23,200 New
23,200 $455,000

Others Institutions Holding RCKT

# of Institutions
194
Shares Held
96.4M
Call Options Held
563K
Put Options Held
418K
View Full List

About ROCKET PHARMACEUTICALS, INC.

RCKT Quotes by TradingView
  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $231M
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email